Oppenheimer Holdings, Inc. Reaffirms Buy Rating for Imperva Inc (IMPV)

Oppenheimer Holdings, Inc. restated their buy rating on shares of Imperva Inc (NYSE:IMPV) in a research report released on Thursday. They currently have a $55.00 price target on the software maker’s stock.

A number of other brokerages also recently commented on IMPV. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the stock a buy rating in a research note on Friday, July 28th. Zacks Investment Research raised shares of Imperva from a hold rating to a strong-buy rating and set a $50.00 price objective for the company in a research note on Tuesday, October 24th. Wells Fargo & Company lowered shares of Imperva from an outperform rating to a market perform rating in a report on Monday, October 9th. BidaskClub lowered shares of Imperva from a hold rating to a sell rating in a report on Saturday, August 5th. Finally, Imperial Capital cut their price target on shares of Imperva from $57.00 to $50.00 and set an outperform rating on the stock in a report on Tuesday, October 10th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. Imperva has an average rating of Hold and an average target price of $52.38.

Shares of Imperva (NYSE:IMPV) traded up $0.60 during trading hours on Thursday, reaching $41.20. 222,500 shares of the company were exchanged, compared to its average volume of 448,881. Imperva has a 52 week low of $35.45 and a 52 week high of $52.40.

Imperva (NYSE:IMPV) last issued its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.11. The company had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. Imperva’s revenue for the quarter was up 22.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.08 earnings per share.

TRADEMARK VIOLATION NOTICE: This news story was posted by Markets Daily and is owned by of Markets Daily. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.themarketsdaily.com/2017/11/13/oppenheimer-holdings-inc-reaffirms-buy-rating-for-imperva-inc-impv.html.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the transaction, the director now directly owns 99,598 shares in the company, valued at $4,341,476.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of IMPV. SG Americas Securities LLC acquired a new position in shares of Imperva in the third quarter worth about $134,000. First Quadrant L P CA acquired a new position in shares of Imperva in the third quarter worth about $136,000. Ameritas Investment Partners Inc. raised its position in shares of Imperva by 18.7% in the second quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after acquiring an additional 464 shares during the period. KCG Holdings Inc. acquired a new position in shares of Imperva in the first quarter worth about $201,000. Finally, Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Imperva by 26.2% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after acquiring an additional 866 shares during the period. Institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply